Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection

Corneal endothelial dystrophy type 2

Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection A Safety and Efficacy Trial of TTHX1114 in People With CED Evaluating Results of Neusidl Corneal Inserter in Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK)